Nutritional supplement for use under physiologically stressful conditions
In one embodiment of the present invention, a pharmaceutically-acceptable single-dosage formulation consists essentially of about 500 mg of vitamin C; about 400 IUs of vitamin D3; about 125 IUs of vitamin E; about 25 mg of vitamin B1; about 3.4 mg of vitamin B2; about 35 mg of niacin; about 35 mg of vitamin B6; about 1.25 mg of folic acid; about 70 mcg of vitamin B12; about 5 mg of pantothenic acid; about 75 mcg of biotin; about 35 mg of magnesium; about 35 mg of zinc; about 1 mg of copper; about 125 mcg of selenium; about 150 mcg of chromium; about 10 mg of alpha lipoic acid; about 35 mg of co-enzyme Q-10; about 400 mcg of lutein; about 125 mcg of lycopene; and at least one or more excipients.
1. A pharmaceutically-acceptable single-dosage formulation, consisting essentially of:
between about 150 mg to about 750 mg of vitamin C;
between about 315 IUs to about 1800 IUs of vitamin D3;
between about 75 IUs to about 150 IUs of vitamin E;
between about 15 mg to about 35 mg of vitamin B1;
between about 1.7 mg to about 5.1 mg of vitamin B2;
between about 20 mg to about 50 mg of niacin;
between about 20 mg to about 50 mg of vitamin B6;
between about 0.5 mg to about 2.5 mg of folic acid;
between about 35 mcg to about 105 mcg of vitamin B12;
between about 2.5 mg to about 7.5 mg of pantothenic acid;
between about 50 mcg to about 450 mcg of biotin;
between about 15 mg to about 55 mg of magnesium;
between about 15 mg to about 55 mg of zinc;
between about 0.5 to about 1.5 mg of copper;
between about 75 mcg to about 175 mcg of selenium;
between about 75 mcg to about 225 mcg of chromium;
between about 10 mg to about 40 mg of alpha lipoic acid;
between about 20 mg to about 50 mg of co-enzyme Q-10;
between about 350 mcg to about 3 mg of lutein;
between about 100 mcg to about 750 mcg of lycopene; and
at least one or more excipients.
2. The pharmaceutically-acceptable single-dosage formulation of claim 1 , wherein the formulation consists essentially of:
about 500 mg of vitamin C;
about 400 IUs of vitamin D3;
about 125 IUs of vitamin E;
about 25 mg of vitamin B1;
about 3.4 mg of vitamin B2;
about 35 mg of niacin;
about 35 mg of vitamin B6;
about 1.25 mg of folic acid;
about 70 mcg of vitamin B12;
about 5 mg of pantothenic acid;
about 300 mcg of biotin;
about 35 mg of magnesium;
about 35 mg of zinc;
about 1 mg of copper;
about 125 mcg of selenium;
about 150 mcg of chromium;
about 10 mg of alpha lipoic acid;
about 35 mg of co-enzyme Q-10;
about 400 mcg of lutein;
about 125 mcg of lycopene; and
at least one or more excipients.
3. The formulation of claim 1 , wherein the single-dosage formulation is administered in a form selected from the group consisting of a pill, a tablet, a caplet, a capsule, a chewable tablet, a quick dissolve tablet, an effervescent tablet, a hard gelatin capsule, and a soft gelatin capsule.
4. The formulation of claim 3 , wherein the single-dosage formulation is administered in a form with an enteric coating.
5. The formulation of claim 1 , wherein the single-dosage formulation is administered in the form of a liquid suspension.
6. The formulation of claim 1 , wherein the single-dosage formulation is administered in the form of a food product.
7. The formulation of claim 1 , wherein the excipients consist essentially of at least one of dicalcium phosphate, microcrystalline cellulose, stearic acid, croscarmellose sodium, magnesium trisillicate, magnesium stearate, hydroxypropyl methylcellulose, hypromellose, titanium dioxide, tripotassium citrate, polyvinyl alcohol, fumed silica, citric acid, polyethylene glycol, or talc.
8. The formulation of claim 1 , wherein the at least one or more excipients consist of:
between about 100 mg to about 300 mg of dicalcium phosphate;
between about 25 mg to about 75 mg of microcrystalline cellulose;
between about 10 mg to about 30 mg of stearic acid;
between about 10 mg to about 30 mg of croscarmellose sodium;
between about 5 mg to about 15 mg of magnesium trisillicate;
between about 5 mg to about 15 mg of magnesium stearate; and
between about 5 mg to about 15 mg of hydroxypropyl methylcellulose.
9. The formulation of claim 8 , wherein the at least one or more excipients consist of:
about 200 mg of dicalcium phosphate;
about 50 mg of microcrystalline cellulose;
about 20 mg of stearic acid;
about 20 mg of croscarmellose sodium;
about 10 mg of magnesium trisillicate;
about 10 mg of magnesium stearate; and
about 10 mg of hydroxypropyl methylcellulose.
10. A pharmaceutically-acceptable single-dosage formulation, consisting of:
between about 150 mg to about 750 mg of ascorbic acid;
between about 315 IUs to about 1800 IUs of cholecalciferol;
between about 75 IUs to about 150 IUs of d-alpha tocopherol succinate;
between about 15 mg to about 35 mg of thiamine mononitrate;
between about 1.7 mg to about 5.1 mg of riboflavin;
between about 20 mg to about 50 mg of niacinamide;
between about 20 mg to about 50 mg of pyridoxine hcl;
between about 0.5 mg to about 2.5 mg of folic acid;
between about 35 mcg to about 105 mcg of cyanocobalamin;
between about 2.5 mg to about 7.5 mg of d-calcium pantothenate;
between about 50 mcg to about 450 mcg of d-biotin;
between about 15 mg to about 55 mg of dimagnesium malate;
between about 15 mg to about 55 mg of zinc bisglycinate chelate;
between about 0.5 to about 1.5 mg of copper amino acid chelate;
between about 75 mcg to about 175 mcg of selenium amino acid chelate;
between about 75 mcg to about 225 mcg of chromium amino acid chelate;
between about 10 mg to about 40 mg of alpha lipoic acid;
between about 20 mg to about 50 mg of co-enzyme Q-10;
between about 350 mcg to about 3 mg of lutein;
between about 100 mcg to about 750 mcg of lycopene; and
at least one or more excipients.
11. The pharmaceutically-acceptable single-dosage formulation of claim 10 , wherein the formulation consists of:
about 500 mg of ascorbic acid;
about 400 IUs of cholecalciferol;
about 125 IUs of d-alpha tocopherol succinate;
about 35 mg of thiamine mononitrate;
about 5.1 mg of riboflavin;
about 50 mg of niacinamide;
about 50 mg of pyridoxine hcl;
about 2.5 mg of folic acid;
about 105 mcg of cyanocobalamin;
about 7.5 mg of d-calcium pantothenate;
about 75 mcg of d-biotin;
about 55 mg of dimagnesium malate;
about 55 mg of zinc bisglycinate chelate;
about 1.5 mg of copper amino acid chelate;
about 175 mcg of selenium amino acid chelate;
about 225 mcg of chromium amino acid chelate;
about 10 mg of alpha lipoic acid;
about 50 mg of co-enzyme Q-10;
about 400 mcg of lutein;
about 125 mcg of lycopene; and
at least one or more excipients.
12. The formulation of claim 10 , wherein the single-dosage formulation is administered in a form selected from the group consisting of a pill, a tablet, a caplet, a capsule, a chewable tablet, a quick dissolve tablet, an effervescent tablet, a hard gelatin capsule, and a soft gelatin capsule.
13. The formulation of claim 12 , wherein the single-dosage formulation is administered in a form with an enteric coating.
14. The formulation of claim 10 , wherein the single-dosage formulation is administered in the form of a liquid suspension.
15. The formulation of claim 10 , wherein the single-dosage formulation is administered in the form of a food product.
16. The formulation of claim 10 , wherein the excipients consist essentially of at least one of dicalcium phosphate, microcrystalline cellulose, stearic acid, croscarmellose sodium, magnesium trisillicate, magnesium stearate, hydroxypropyl methylcellulose, hypromellose, titanium dioxide, tripotassium citrate, polyvinyl alcohol, fumed silica, citric acid, polyethylene glycol, or talc.
17. The formulation of claim 10 , wherein the at least one or more excipients consist of:
between about 100 mg to about 300 mg of dicalcium phosphate;
between about 25 mg to about 75 mg of microcrystalline cellulose;
between about 10 mg to about 30 mg of stearic acid;
between about 10 mg to about 30 mg of croscarmellose sodium;
between about 5 mg to about 15 mg of magnesium trisillicate;
between about 5 mg to about 15 mg of magnesium stearate; and
between about 5 mg to about 15 mg of hydroxypropyl methylcellulose.
18. The formulation of claim 17 , wherein the at least one or more excipients consist of:
about 200 mg of dicalcium phosphate;
about 50 mg of microcrystalline cellulose;
about 20 mg of stearic acid;
about 20 mg of croscarmellose sodium;
about 10 mg of magnesium trisillicate;
about 10 mg of magnesium stearate; and
about 10 mg of hydroxypropyl methylcellulose.
19. A pharmaceutically-acceptable single-dosage formulation, consisting of:
between about 150 mg to about 750 mg of ascorbic acid;
between about 315 IUs to about 1800 IUs of cholecalciferol;
between about 75 IUs to about 150 IUs of d-alpha tocopherol succinate;
between about 15 mg to about 35 mg of thiamine mononitrate;
between about 1.7 mg to about 5.1 mg of riboflavin;
between about 20 mg to about 50 mg of niacinamide;
between about 20 mg to about 50 mg of pyridoxine hcl;
between about 0.5 mg to about 2.5 mg of folic acid;
between about 35 mcg to about 105 mcg of cyanocobalamin;
between about 2.5 mg to about 7.5 mg of d-calcium pantothenate;
between about 50 mcg to about 450 mcg of d-biotin;
between about 15 mg to about 55 mg of dimagnesium malate;
between about 15 mg to about 55 mg of zinc bisglycinate chelate;
between about 0.5 to about 1.5 mg of copper amino acid chelate;
between about 75 mcg to about 175 mcg of selenium amino acid chelate;
between about 75 mcg to about 225 mcg of chromium amino acid chelate;
between about 10 mg to about 40 mg of alpha lipoic acid;
between about 20 mg to about 50 mg of co-enzyme Q-10;
between about 350 mcg to about 3 mg of lutein;
between about 100 mcg to about 750 mcg of lycopene;
between about 100 mg to about 300 mg of dicalcium phosphate;
between about 25 mg to about 75 mg of microcrystalline cellulose;
between about 10 mg to about 30 mg of stearic acid;
between about 10 mg to about 30 mg of croscarmellose sodium;
between about 5 mg to about 15 mg of magnesium trisillicate;
between about 5 mg to about 15 mg of magnesium stearate; and
between about 5 mg to about 15 mg of hydroxypropyl methylcellulose;
wherein the single-dosage formulation is administered in a form selected from a group consisting of a pill, a tablet, a caplet, a capsule, a chewable tablet, a quick dissolve tablet, an effervescent tablet, a hard gelatin capsule, a soft gelatin capsule, a liquid suspension or a food product.
20. The pharmaceutically-acceptable single-dosage formulation of claim 19 , wherein the formulation consists of:
about 500 mg of ascorbic acid;
about 400 IUs of cholecalciferol;
about 125 IUs of d-alpha tocopherol succinate;
about 35 mg of thiamine mononitrate;
about 5.1 mg of riboflavin;
about 50 mg of niacinamide;
about 50 mg of pyridoxine hcl;
about 2.5 mg of folic acid;
about 105 mcg of cyanocobalamin;
about 7.5 mg of d-calcium pantothenate;
about 75 mcg of d-biotin;
about 55 mg of dimagnesium malate;
about 55 mg of zinc bisglycinate chelate;
about 1.5 mg of copper amino acid chelate;
about 175 mcg of selenium amino acid chelate;
about 225 mcg of chromium amino acid chelate;
about 10 mg of alpha lipoic acid;
about 50 mg of co-enzyme Q-10;
about 400 mcg of lutein;
about 125 mcg of lycopene;
about 200 mg of dicalcium phosphate;
about 50 mg of microcrystalline cellulose;
about 20 mg of stearic acid;
about 20 mg of croscarmellose sodium;
about 10 mg of magnesium trisillicate;
about 10 mg of magnesium stearate; and
about 10 mg of hydroxypropyl methylcellulose.